title: Febuxostat treatment for gout: what the clinician needs to know.
abstract: Febuxostat is a new non-purine based inhibitor of xanthine oxidase that will be a useful addition to the drugs available to treat gout. This short review covers general principles of the management of gout and then focuses on practical aspects and use of febuxostat.
authors.affiliation: Penn Presbyterian Medical Center, Rheumatology, 2  fl. 3910 Building, 39  and Market Street, Philadelphia, PA 19104, USA.
authors.forename: Lan X
authors.initials: LX
authors.lastname: Chen
authors.forename: H Ralph
authors.initials: HR
authors.lastname: Schumacher